Quick Answer
PALVELLA THERAPEUTICS, INC. reported Stockholders Equity of $27.98 million for the year ending 2025.
- PALVELLA THERAPEUTICS, INC. showed a decrease of -55.3% in Stockholders Equity from 2024 to 2025.
- This data is from PALVELLA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $14.23 million | Q2 2015: $11.15 million | Q3 2015: $33.65 million | Q1 2016: $27.18 million | Q2 2016: $37.29 million | Q3 2016: $31.48 million | Q1 2017: $18.04 million | Q2 2017: $9.33 million | Q3 2017: $4.56 million | Q1 2018: $50.69 million | Q2 2018: $55.32 million | Q3 2018: $50.26 million | Q1 2019: $30.16 million | Q2 2019: $19.49 million | Q3 2019: $20.64 million | Q1 2020: $49.81 million | Q2 2020: $46.67 million | Q3 2020: $43.69 million | Q1 2021: $38.24 million | Q2 2021: $46.72 million | Q3 2021: $53.85 million | Q1 2022: $53.45 million | Q2 2022: $44.37 million | Q3 2022: $35.77 million | Q1 2023: $15.46 million | Q2 2023: $40.50 million | Q3 2023: $30.51 million | Q1 2024: -$76.87 million | Q2 2024: -$80.83 million | Q3 2024: -$87.40 million | Q1 2025: $55.58 million | Q2 2025: $47.78 million | Q3 2025: $38.68 million.
- Over the full 14 years of available data (2012 to 2025), PALVELLA THERAPEUTICS, INC.'s Stockholders Equity has grown by 5,545.1%.
- Historical annual values: Fiscal year 2025: $27.98 million | Fiscal year 2024: $62.61 million | Fiscal year 2023: -$74.48 million | Fiscal year 2022: -$93.78 million | Fiscal year 2021: $50.76 million | Fiscal year 2020: $31.03 million | Fiscal year 2019: $51.35 million | Fiscal year 2018: $39.94 million | Fiscal year 2017: $11.52 million | Fiscal year 2016: $25.23 million | Fiscal year 2015: $31.13 million | Fiscal year 2014: $18.01 million | Fiscal year 2013: $585.0 thousand | Fiscal year 2012: $495.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: